603139 Stock Overview
Engages in the research and development, production, and sale of pharmaceutical products in China.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Shaanxi Kanghui Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥14.90 |
52 Week High | CN¥21.60 |
52 Week Low | CN¥8.81 |
Beta | 0.20 |
11 Month Change | 18.82% |
3 Month Change | 6.13% |
1 Year Change | -16.76% |
33 Year Change | -12.25% |
5 Year Change | -10.83% |
Change since IPO | -28.98% |
Recent News & Updates
Shareholder Returns
603139 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 22.2% | 0.05% | -1.6% |
1Y | -16.8% | -11.8% | -19.6% |
Return vs Industry: 603139 underperformed the CN Pharmaceuticals industry which returned -11.8% over the past year.
Return vs Market: 603139 exceeded the CN Market which returned -19.6% over the past year.
Price Volatility
603139 volatility | |
---|---|
603139 Average Weekly Movement | 7.1% |
Pharmaceuticals Industry Average Movement | 5.2% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 9.0% |
10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 603139 has not had significant price volatility in the past 3 months.
Volatility Over Time: 603139's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 952 | Yanling Wang | www.sxkh.com |
Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular, tranquilizer, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company was founded in 2009 and is based in Xianyang, China.
Shaanxi Kanghui Pharmaceutical Co., Ltd. Fundamentals Summary
603139 fundamental statistics | |
---|---|
Market cap | CN¥1.49b |
Earnings (TTM) | -CN¥33.28m |
Revenue (TTM) | CN¥676.54m |
2.2x
P/S Ratio-44.7x
P/E RatioIs 603139 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603139 income statement (TTM) | |
---|---|
Revenue | CN¥676.54m |
Cost of Revenue | CN¥494.22m |
Gross Profit | CN¥182.31m |
Other Expenses | CN¥215.59m |
Earnings | -CN¥33.28m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 30, 2024
Earnings per share (EPS) | -0.33 |
Gross Margin | 26.95% |
Net Profit Margin | -4.92% |
Debt/Equity Ratio | 57.7% |
How did 603139 perform over the long term?
See historical performance and comparison